GammaFlu

GammaFlu is a preclinical whole inactivated influenza virus vaccine being developed by Gamma Vaccines for broad protection against **seasonal influenza** and **pandemic influenza** caused by **Influenza A** and **Influenza B**. The vaccine uses a proprietary **gamma-irradiation photon inactivation** process to completely inactivate whole virus while preserving native viral protein antigen structure, with the goal of inducing both **humoral** and **T-cell immune responses** and providing cross-protective, potentially longer-lasting immunity than conventional seasonal influenza vaccines. Company materials describe GammaFlu as the lead program on Gamma Vaccines' platform and note an expected potential for improved efficacy in older adults.

Brand names

GammaFlu

Other names

GammaFlu